Celltrion
068270.KS
#829
Rank
HK$217.86 B
Marketcap
HK$968.73
Share price
0.38%
Change (1 day)
6.12%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): HK$8.34

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$8.33. In 2023 the company made an earnings per share (EPS) of HK$21.54 a decrease over its 2022 EPS that were of HK$22.00.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$8.34
2023HK$21.54-2.08%
2022HK$22.00-11.72%
2021HK$24.922.03%
2020HK$24.4382.8%
2019HK$13.3618.31%
2018HK$11.29-36.33%
2017HK$17.74161.25%
2016HK$6.792.86%
2015HK$6.6017.84%
2014HK$5.605.87%
2013HK$5.29-70.85%
2012HK$18.15134.09%
2011HK$7.7543.59%
2010HK$5.4074.49%
2009HK$3.09317.8%
2008HK$0.74-71.7%
2007HK$2.62